QUICK REFERENCE. Pseudomonas aeruginosa. (Pseudomonas sp. Xantomonas maltophilia, Acinetobacter sp. & Flavomonas sp.)

Similar documents
Aberdeen Hospital. Antibiotic Susceptibility Patterns For Commonly Isolated Organisms For 2015

2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST

2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine

2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

2015 Antibiotic Susceptibility Report

2016 Antibiotic Susceptibility Report

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting

INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER

RCH antibiotic susceptibility data

Table 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities.

Concise Antibiogram Toolkit Background

Antimicrobial Susceptibility Testing: Advanced Course

CONTAGIOUS COMMENTS Department of Epidemiology

EUCAST recommended strains for internal quality control

CUMULATIVE ANTIBIOGRAM

CONTAGIOUS COMMENTS Department of Epidemiology

European Committee on Antimicrobial Susceptibility Testing

Routine internal quality control as recommended by EUCAST Version 3.1, valid from

microbiology testing services

Mercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016

Antimicrobial Susceptibility Patterns

Performance Information. Vet use only

European Committee on Antimicrobial Susceptibility Testing

C&W Three-Year Cumulative Antibiogram January 2013 December 2015

Advanced Practice Education Associates. Antibiotics

BACTERIAL SUSCEPTIBILITY REPORT: 2016 (January 2016 December 2016)

Cipro for gram positive cocci in urine

Antimicrobial susceptibility

2010 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Children s Hospital

VPM 201-Lab 6 Bovine Mastitis, Bacillus & Mastitis (2012)

Interactive session: adapting to antibiogram. Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe

Antibiotic Stewardship Program (ASP) CHRISTUS SETX

Antimicrobial Susceptibility Testing: The Basics

Do clinical microbiology laboratory data distort the picture of antibiotic resistance in humans and domestic animals?

Intrinsic, implied and default resistance

CONTAGIOUS COMMENTS Department of Epidemiology

BactiReg3 Event Notes Module Page(s) 4-9 (TUL) Page 1 of 21

2009 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Childrens Hospital

جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی

Approach to pediatric Antibiotics

What s new in EUCAST methods?

Cleaning and Disinfection Protocol for Gram-Negative and Gram-Positive Bacteria, including Antibiotic Resistant Bacteria

Antimicrobial Susceptibility Summary 2011

Cleaning and Disinfection Protocol Vegetative Bacteria

The β- Lactam Antibiotics. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018

The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing

Antimicrobial Stewardship Strategy: Antibiograms

Super Bugs and Wonder Drugs: Protecting the One While Respecting the Many

Understanding the Hospital Antibiogram

SYMMETRY FOAMING HAND SANITIZER with Aloe & Vitamin E Technical Data

Antimicrobial Susceptibility Summary 2012

Pathogens commonly isolated from selected diseases

4 th and 5 th generation cephalosporins. Naderi HR Associate professor of Infectious Diseases

2 0 hr. 2 hr. 4 hr. 8 hr. 10 hr. 12 hr.14 hr. 16 hr. 18 hr. 20 hr. 22 hr. 24 hr. (time)

HUSRES Annual Report 2007 Martti Vaara.

TABLE OF CONTENTS. Urine - Gram Positive Susceptibility Reporting 1 Staphylococcus species, MRSA...11

Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method.

Antimicrobial Resistance Trends in the Province of British Columbia

Evaluation of the BIOGRAM Antimicrobial Susceptibility Test System

Enterobacter aerogenes

Antimicrobials. Antimicrobials

Childrens Hospital Antibiogram for 2012 (Based on data from 2011)

Project Summary. Impact of Feeding Neomycin on the Emergence of Antibiotic Resistance in E. coli O157:H7 and Commensal Organisms

THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS

Antibiotic Susceptibility of Bacterial Infections in Arizona Companion Animal Species from January 2015 to December 2016

Compliance of manufacturers of AST materials and devices with EUCAST guidelines

Leveraging the Lab and Microbiology Department to Optimize Stewardship

Medicinal Chemistry 561P. 2 st hour Examination. May 6, 2013 NAME: KEY. Good Luck!

Infectious Disease: Drug Resistance Pattern in New Mexico

Infection Linelist. Infections Occurred Between 10/1/ :00:00 AM To 11/1/ :00:00 AM 2RCW2. Gastroenteritis (Adult) Urinary Tract

Bacterial Pathogens in Urinary Tract Infection and Antibiotic Susceptibility Pattern from a Teaching Hospital, Bengaluru, India

Brief reports. Heat stability of the antimicrobial activity of sixty-two antibacterial agents

Antimicrobial resistance at different levels of health-care services in Nepal

Compliance of manufacturers of AST materials and devices with EUCAST guidelines

In Vitro Antimicrobial Activity of CP-99,219, a Novel Azabicyclo-Naphthyridone

High Antibiotic Resistance Pattern Observed in Bacterial Isolates from a Tertiary Hospital in South East Nigeria

Taking Action to Prevent and Manage Multidrug-resistant Organisms and C. difficile in the Nursing Home: Part 1 Reviewing the organisms

National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults

Principles of Infectious Disease. Dr. Ezra Levy CSUHS PA Program

SYMMETRY ANTIMICROBIAL FOAMING HANDWASH with 0.3% PCMX Technical Data

BACTERIOLOGICALL STUDY OF MICROORGANISMS ON MOBILES AND STETHOSCOPES USED BY HEALTH CARE WORKERS IN EMERGENCY AND ICU S

Over the past several decades, the frequency of. Resistance Patterns Among Nosocomial Pathogens* Trends Over the Past Few Years. Ronald N.

GENERAL NOTES: 2016 site of infection type of organism location of the patient

Aerobic bacterial infections in a burns unit of Sassoon General Hospital, Pune

HOSPITAL-ACQUIRED INFECTIONS AND QASM PATIENTS

Recommendations Regarding Use of Rapid Blood Pathogen Identification Panel Data

Antimicrobial Resistance Trends in the Province of British Columbia. August Epidemiology Services British Columbia Centre for Disease Control

January 2014 Vol. 34 No. 1

Mark Your Calendars Now! Next Event Ships: September 14, 2015

Recommendations for Implementation of Antimicrobial Stewardship Restrictive Interventions in Acute Hospitals in Ireland

York Chairman David B. Jones, MD

Policy # MI_AST Department of Microbiology. Page Quality Manual

Similar to Penicillins: -Chemically. -Mechanism of action. -Toxicity.

BSAC standardized disc susceptibility testing method (version 8)

ADC 2016 Report on Bacterial Resistance in Cultures from SEHOS and General Practitioners in Curaçao

Principles of Antibiotics Use & Spectrum of Some

Mike Apley Kansas State University

Transcription:

Pseudomonas aeruginosa (Pseudomonas sp. Xantomonas maltophilia, Acinetobacter sp. & Flavomonas sp.) Description: Greenish gray colonies with some beta-hemolysis around each colony on blood agar (BAP), clear pale colonies on maconkey agar (MAC) & no growth on Columbia agar (CNA). Source of infection: Primary infection of ears, respiratory and often wounds. Various species can often contaminate un-treated water sources. Routinely susceptible to: Amikacin, Baytril, Ciprofloxacin, Gentamicin, Polymixin B, Ceftazidime, Marbofloxacin, and often Ticarcillin. Routinely resistant to: Ampicillin, Cephalothin, Clavamox, Clindamycin, Chloramphenicol, Erythromycin, Penicillin, Tetracycline, Sulfa/Trimeth, Doxycycline and Nitrofurantoin, NOTES: The drug of choice for Xanthomonas is Sulfa/Trimeth. Species other than Pseudomonas aeruginosa are often susceptible to Sulfa/Trimeth.

Staphylococcus intermedius / aureus (Staphylococcus sp. Micrococcus sp., Corynebacterium sp. & Bacillus sp.) Description: White / light yellow to opaque grayish colonies & beta-hemolysis around each colony on blood agar (BAP), no growth on maconkey agar (MAC) & same as blood agar on Columbia agar (CNA). Source of infection: Primary infection of skin and ears, but can infect all areas of the body. Staphylococcus sp. Micrococcus, Corynebacterium often make up the NORMAL skin flora. Bacillus sp. is a common soil contaminant. Routinely susceptible to: Amikacin, Baytril, Cephalothin, Ciprofloxacin, Clavamox, Chloramphenicol, Polymixin B, Tetracycline, Sulfa/Trimeth, Neomycin, Nitrofuratoin, Clindamycin, Erythromycin Ceftazidime, Marbofloxacin, Doxycycline and Ticarcillin. Routinely resistant to: Ampicillin and Penicillin (except: for Bacillus). NOTES: Staph intermedius is routinely resistant to Tetracycline & Doxycyxcline and Staph aureus is routinely resistant to Polymyxin B. Oxacillin resistant strains are known as MRSA (Methacillin-resistant Staph aureus).

Proteus mirabilis (Proteus sp.) Description: Opaque grayish colonies on blood agar (BAP) with a rapid spreading appearance, clear opaque colonies on maconkey agar (MAC) & no growth on Columbia agar (CNA). Source of infection: Primary infection of urinary tract and ears, but can infect all areas of the body. Routinely susceptible to: Ampicillin, Amikacin, Baytril, Cephalothin, Ciprofloxacin, Clavamox, Chloramphenicol, Sulfa/Trimeth, Neomycin, Ceftazidime, Marbofloxacin and Ticarcillin. Routinely resistant to: Clindamycin and Erythromycin, Tetracycline, Doxycycline and Nitrofurantoin. NOTES: Most often Proteus will swarm the blood agar plate (BAP), however, on some occasions it will produce a stunted or reduced swarming effect.

Streptococcus faecalis (Strep faecium, Group D enterococcus) Description: Opaque to grayish colonies on blood agar (BAP), no growth on maconkey agar (MAC) & same as blood agar on Columbia agar (CNA). Source of infection: Primary infection of urinary tract, skin and ears, but can infect all areas of the body. Routinely susceptible to: Ampicillin, Penicillin, Baytril, Ciprofloxacin, Clavamox, Chloramphenicol, Nitrofuratoin, Clindamycin, Erythromycin Ceftazidime, Marbofloxacin, and Ticarcillin. Routinely resistant to: Amikacin, Neomycin, Cephalothin, Tetracycline, Doxycycline and sometimes Polymixin B & sometimes Sulfa/Trimeth. NOTES: This organism can also be resistant to Vancomycin and is known as VRE (Vancomycin-resistant enterococcus).

Enterobacter cloacae (Enterobacter sp., Klebsiella sp., Citrobacter sp.) Description: Opaque grayish / white colonies on blood agar (BAP), pink / light pink mucoid colonies on maconkey agar (MAC) & no growth on Columbia agar (CNA). Source of infection: Primary infection of urinary tract and ears, but can infect all areas of the body. Normally found in feces. Routinely susceptible to: Amikacin, Baytril, Ciprofloxacin, Tetracycline, Doxycycline, Chloramphenicol, Sulfa/Trimeth, Neomycin, Ceftazidime, Marbofloxacin, Nitrofurantoin and Ticarcillin. Routinely resistant to: Ampicillin, Penicillin, Clavamox, Cephalothin Clindamycin and Erythromycin. NOTES: Klebsiella sp. will often be susceptible to Cephalothin, which helps to separate it from Enterobacter sp. (Citrobacter sp. will not be mucoid)

Escherichia coli (Escherichia sp., Pasteurella sp. and Salmonella sp.) Description: Opaque grayish colonies on blood agar (BAP), pink, flat dry colonies on maconkey agar (MAC) & no growth on Columbia agar (CNA). Pasteurella only grows on the blood agar plate. Source of infection: Primary infection of urinary tract, but can infect all areas of the body. Normally found in feces. Routinely susceptible to: Ampicillin, Amikacin, Baytril, Cephalothin, Ciprofloxacin, Clavamox, Chloramphenicol, Polymixin B, Tetracycline, Sulfa/Trimeth, Neomycin, Nitrofuratoin, Ceftazidime, Marbofloxacin, Doxycycline and Ticarcillin. Routinely resistant to: Clindamycin and Erythromycin. NOTES: There are always exceptions to the rule and E. coli can become very resistant.

Beta-Hemolytic group A,B C, F, & G Streptococcus (Streptococcus sp.& Viridans Strep) Description: Opaque to grayish colonies on blood agar (BAP) with distinct clearing zones around the colonies (beta-hemolysis), no growth on maconkey agar (MAC) & same as blood agar on Columbia agar (CNA). Source of infection: Primary infection of ears and skin, but can infect all areas of the body. Routinely susceptible to: Ampicillin, Penicillin, Baytril, Ciprofloxacin, Clavamox, Chloramphenicol, Nitrofuratoin, Clindamycin, Erythromycin Ceftazidime, Marbofloxacin, Cephalothin, Tetracycline, Doxycycline and Ticarcillin. Routinely resistant to: Amikacin, Neomycin and sometimes Sulfa/Trimeth. NOTE: BAP above has both Staphylococcus aureus & beta-streptococcus to show the colony size difference.

Additional Organisms: Alpha-hemolytic Streptococcus Small greenish-gray colonies. (see beta Strep for susceptibility patterns) Pasteurella multocida This organism is a gram negative rod that only grows on blood agar plate, grayishwhite colonies and does not grow on maconkey agar. (see E. coli for susceptibility patterns)

Anaerobic Bacteria (Bacteroides, Clostridium, Peptostreptococcus) Source of infection: These organisms routinely infect the areas of the body that have a reduced access to oxygen: body fluids, inner ear canal, blood stream and deep wounds. Often they have a very foul odor. Routinely susceptible to: Bacteroides: Metronidazole, Chloramphencicol, Ticarcillin/Clavulanate, Piperacillin, Clavamox, Imipenem and Clindamicin. Clostridium: Penicillin G, Chloramphenicol, Piperacillin, Metronidozole, Imipenem and Ampicillin/sulbactam. Peptostreptococcus: B-lactam- antibiotics, Ticarcillin, Cefotaxime, Clindamycin and Metronidazole. NOTE: Most anaerobic bacteria can be treated with Metronidazole.